161 related articles for article (PubMed ID: 30753557)
1. A Novel Enzyme Immunoassay for the Detection of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine.
Schubert B; Pitterl F; Saxl B; Pavlic M
J Anal Toxicol; 2019 Jun; 43(5):364-368. PubMed ID: 30753557
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis).
Belsey SL; Couchman L; Flanagan RJ
J Anal Toxicol; 2014 Sep; 38(7):438-43. PubMed ID: 24925983
[TBL] [Abstract][Full Text] [Related]
3. Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogeneous immunoassay for the detection of buprenorphine and norbuprenorphine in urine.
Wang G; Vincent M; Rodrigues W; Agrawal A; Moore C; Barhate R; Abolencia E; Coulter C; Soares J; Zheng YF; Taylor C; Morjana N
J Anal Toxicol; 2007 Sep; 31(7):377-82. PubMed ID: 17725885
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
[TBL] [Abstract][Full Text] [Related]
5. Rapid, hydrolysis-free, dilute-and-shoot method for the determination of buprenorphine, norbuprenorphine and their glucuronides in urine samples using UHPLC-MS/MS.
Agostini M; Renzoni C; Pierini E; Piergiovanni M; Termopoli V; Famiglini G; Palma P; Cappiello A
J Pharm Biomed Anal; 2019 Mar; 166():236-243. PubMed ID: 30660808
[TBL] [Abstract][Full Text] [Related]
6. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry.
Kronstrand R; Seldén TG; Josefsson M
J Anal Toxicol; 2003 Oct; 27(7):464-70. PubMed ID: 14607001
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of buprenorphine LUCIO immunoassay versus GC-MS using urines from a workplace drug testing program.
Alves MN; Piccinotti A; Tameni S; Polettini A
J Anal Toxicol; 2013 Apr; 37(3):175-8. PubMed ID: 23408251
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Immunalysis microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine.
Miller EI; Torrance HJ; Oliver JS
J Anal Toxicol; 2006 Mar; 30(2):115-9. PubMed ID: 16620543
[TBL] [Abstract][Full Text] [Related]
9. Issues pertaining to the analysis of buprenorphine and its metabolites by gas chromatography-mass spectrometry.
Wang YS; Lin DL; Yang SC; Wu MY; Liu RH; Su LW; Cheng PS; Liu C; Fuh MR
J Chromatogr A; 2010 Mar; 1217(10):1688-94. PubMed ID: 20122691
[TBL] [Abstract][Full Text] [Related]
10. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride.
Birch MA; Couchman L; Pietromartire S; Karna T; Paton C; McAllister R; Marsh A; Flanagan RJ
J Anal Toxicol; 2013 May; 37(4):233-6. PubMed ID: 23471956
[TBL] [Abstract][Full Text] [Related]
11. Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine.
Shaikh S; Hull MJ; Bishop KA; Griggs DA; Long WH; Nixon AL; Flood JG
J Anal Toxicol; 2008 Jun; 32(5):339-43. PubMed ID: 18544218
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment.
Böttcher M; Beck O
J Anal Toxicol; 2005; 29(8):769-76. PubMed ID: 16356333
[TBL] [Abstract][Full Text] [Related]
13. A simple gas chromatography-mass spectrometry procedure for the simultaneous determination of buprenorphine and norbuprenorphine in human urine.
Fuller DC
J Anal Toxicol; 2008 Oct; 32(8):626-30. PubMed ID: 19007513
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of buprenorphine and norbuprenorphine in urine using liquid chromatography tandem mass spectrometry.
Fox EJ; Tetlow VA; Allen KR
J Anal Toxicol; 2006 May; 30(4):238-44. PubMed ID: 16803661
[TBL] [Abstract][Full Text] [Related]
15. Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry.
McMillin GA; Davis R; Carlisle H; Clark C; Marin SJ; Moody DE
J Anal Toxicol; 2012 Mar; 36(2):81-7. PubMed ID: 22337776
[TBL] [Abstract][Full Text] [Related]
16. Do all screening immunoassay positive buprenorphine samples need to be confirmed?
Saleem M; Martin H; Tolya A; Coates P
Ann Clin Biochem; 2017 Nov; 54(6):707-711. PubMed ID: 28121168
[TBL] [Abstract][Full Text] [Related]
17. Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine.
Kronstrand R; Nyström I; Andersson M; Gunnarsson L; Hägg S; Josefsson M; Ahlner J
J Anal Toxicol; 2008 Oct; 32(8):586-93. PubMed ID: 19007507
[TBL] [Abstract][Full Text] [Related]
18. Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry.
Vincent F; Bessard J; Vacheron J; Mallaret M; Bessard G
J Anal Toxicol; 1999; 23(4):270-9. PubMed ID: 10445490
[TBL] [Abstract][Full Text] [Related]
19. A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.
Melanson SE; Snyder ML; Jarolim P; Flood JG
J Anal Toxicol; 2012 Apr; 36(3):201-6. PubMed ID: 22417836
[TBL] [Abstract][Full Text] [Related]
20. Rapid quantification of buprenorphine-glucuronide and norbuprenorphine-glucuronide in human urine by LC-MS-MS.
Hegstad S; Khiabani HZ; Øiestad EL; Berg T; Christophersen AS
J Anal Toxicol; 2007 May; 31(4):214-9. PubMed ID: 17555645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
